Maraviroc - a CCR5 antagonist for the treatment of HIV-1 infection

被引：39
|
作者：
Van Der Ryst, Elna [1 ]
机构：
[1] Res Network, Sandwich, Kent, England
来源：
FRONTIERS IN IMMUNOLOGY | 2015年 / 6卷
关键词：
HIV; CCR5; antagonist; HIV-1; RNA; tropism; antiretroviral drug; CLINICAL-TRIALS; RECEPTOR; VIRUS; ENTRY; RESISTANCE;
D O I：
10.3389/fimmu.2015.00277
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Treatment of HIV infection with the CCR5 antagonist maraviroc
    Kromdijk, Wiete
    Huitema, Alwin D. R.
    Mulder, Jan Willem
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (07) : 1215 - 1223
  • [2] Pharmacotherapy of HIV-1 Infection: Focus on CCR5 Antagonist Maraviroc
    Latinovic, Olga
    Kuruppu, Janaki
    Davis, Charles
    Le, Nhut
    Heredia, Alonso
    [J]. CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2009, 1 : 1497 - 1510
  • [3] Maraviroc - The first CCR5 antagonist for the treatment of HIV
    Girotto, Jennifer E.
    [J]. FORMULARY, 2007, 42 (10) : 601 - 608
  • [4] Maraviroc: A CCR5-receptor antagonist for the treatment of HIV-1 infection
    Lieberman-Blum, Sharon S.
    Fung, Horatio B.
    Bandres, Juan C.
    [J]. CLINICAL THERAPEUTICS, 2008, 30 (07) : 1228 - 1250
  • [5] Maraviroc: A coreceptor CCR5 antagonist for management of HIV infection
    Yost, Raymond
    Pasquale, Timothy R.
    Sahloff, Eric G.
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2009, 66 (08) : 715 - 726
  • [6] Drug evaluation: Maraviroc, a chemokine CCR5 receptor antagonist for the treatment of HIV infection and AIDS
    Meanwell, Nicholas A.
    Kadow, John F.
    [J]. CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2007, 8 (08) : 669 - 681
  • [7] Vicriviroc: a CCR5 antagonist for treatment-experienced patients with HIV-1 infection
    Kuemmerle, Tim
    Lehmann, Clara
    Hartmann, Pia
    Wyen, Christoph
    Faetkenheuer, Gerd
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2009, 18 (11) : 1773 - 1785
  • [8] Investigating HIV-1 Resistance to CCR5 Antagonist Maraviroc for the Design of New Prevention Strategies
    Flynn, Jacqueline K.
    Roche, Michael
    Paukovics, Geza
    Salimi, Hamid
    Duncan, Renee C.
    Moore, Miranda S.
    Ellet, Anne
    Gray, Lachlan R.
    Jubb, Becky
    Westby, Mike
    Purcell, Damian F. J.
    Lewin, Sharon R.
    Lee, Benhur
    Payne, Richard J.
    Churchill, Melissa J.
    Gorry, Paul R.
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2014, 30 : A212 - A212
  • [9] Use of maraviroc, the first CCR5 receptor antagonist, in HIV treatment regimens
    Kravchenko, A. V.
    [J]. TERAPEVTICHESKII ARKHIV, 2013, 85 (11): : 125 - +
  • [10] Overcoming hERG affinity in the discovery of maraviroc; A CCR5 antagonist for the treatment of HIV
    Price, David A.
    Armour, Duncan
    de Groot, Marcel
    Leishman, Derek
    Napier, Carolyn
    Perros, Manos
    Stammen, Blanda L.
    Wood, Anthony
    [J]. CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2008, 8 (13) : 1140 - 1151
12345